|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.84 USD | +2.34% |
|
+4.21% | +26.19% |
| 07-09 | NeoGenomics Launches FDA-Approved PTEN IHC Companion Diagnostic For Prostate Cancer | CI |
| 06-25 | NeoGenomics, Inc. Announces Appointment of Carolyn Starrett to Board of Directors | CI |
| Market Cap | 1.93B 1.69B 1.56B 1.43B 2.71B 186B 2.76B 18.63B 7.3B 90.99B 7.25B 7.1B 314B | P/E 2026 * |
-33.3x | P/E 2027 * | -51.7x |
|---|---|---|---|---|---|
| Enterprise Value | 1.93B 1.69B 1.56B 1.43B 2.71B 186B 2.76B 18.63B 7.3B 90.99B 7.25B 7.1B 314B | EV / Sales 2026 * |
2.41x | EV / Sales 2027 * | 2.19x |
| Free-Float |
97.95% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: NeoGenomics, Inc.
| 1 day | +2.34% | ||
| 1 week | +4.21% | ||
| Current month | +1.71% | ||
| 1 month | +33.81% | ||
| 3 months | +70.97% | ||
| 6 months | +15.67% | ||
| Current year | +26.19% |
| 1 week | 13.8 |  | 14.98 |
| 1 month | 10.26 | | 15.57 |
| Current year | 7.06 | | 15.57 |
| 1 year | 4.72 | | 15.57 |
| 3 years | 4.72 | | 21.22 |
| 5 years | 4.72 | | 54.74 |
| 10 years | 4.72 | | 61.57 |
| Manager | Title | Age | Since |
|---|---|---|---|
Anthony Zook
CEO | Chief Executive Officer | 65 | 2025-03-31 |
Abhishek Jain
DFI | Director of Finance/CFO | 57 | 2026-03-01 |
Warren Stone
PSD | President | 53 | 2025-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Lynn Tetrault
CHM | Chairman | 64 | 2021-10-06 |
Stephen Kanovsky
BRD | Director/Board Member | 63 | 2017-07-18 |
Michael Kelly
BRD | Director/Board Member | 69 | 2020-07-14 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/23/26 | Free | Director | 23,909 | 0.0184% | ||
| 6/15/26 | Sell | Chairman | -5,307 | 0.0041% | ||
| 6/9/26 | Sell | Chairman | -5,307 | 0.0041% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.34% | +4.21% | +115.07% | -14.02% | 1.89B | |
| -2.72% | -1.66% | +80.07% | +444.45% | 39.72B | |
| +3.66% | +1.51% | +14.77% | +32.51% | 22.3B | |
| +1.21% | -0.50% | -20.28% | -39.12% | 7.43B | |
| +2.57% | -3.96% | +13.58% | +101.83% | 4.83B | |
| +0.55% | +4.79% | +16.51% | +47.05% | 2.99B | |
| -6.73% | -5.99% | -24.48% | +818.01% | 1.96B | |
| -0.50% | +21.52% | -3.79% | -63.57% | 1.92B | |
| +3.17% | +13.20% | +39.25% | -15.68% | 1.85B | |
| +6.62% | +4.25% | +28.08% | +6.42% | 1.77B | |
| Average | +1.02% | +2.18% | +25.88% | +131.79% | 8.67B | |
| Weighted average by Cap. | +0.05% | +0.19% | +43.37% | +232.65% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 800M 699M 647M 594M 1.12B 77.11B 1.14B 7.72B 3.03B 37.69B 3.01B 2.94B 130B | 881M 770M 712M 654M 1.24B 84.84B 1.26B 8.49B 3.33B 41.47B 3.31B 3.23B 143B |
| Net income | -57.81M -50.52M -46.74M -42.9M -81.16M -5.57B -82.62M -557M -219M -2.72B -217M -212M -9.39B | -37.05M -32.37M -29.95M -27.49M -52.01M -3.57B -52.95M -357M -140M -1.74B -139M -136M -6.01B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-16 | US$14.84 | +2.34% | 4,269,641 |
| 26-07-15 | US$14.50 | +1.90% | 3,068,688 |
| 26-07-14 | US$14.23 | +0.85% | 1,503,301 |
| 26-07-13 | US$14.11 | 0.00% | 1,543,181 |
| 26-07-10 | US$14.11 | -4.21% | 1,377,878 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NEO Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
